T
Theravance Biopharma Inc
Q2 2025 earnings expected
Quarter
Apr – Jun
Expected
August 14, 2025(ET)
Revenue
This quarter$26M
Analyst estimate$26M▲ +1.0%
Year ago (Jun '24)$14M▲ +83.7%
EPS
This quarter-$0.08
Analyst estimate$0.67▼ -111.9%
Year ago (Jun '24)-$0.13▲ +38.5%
Revenue Growth Trajectory
+15%YoY
Last 6 quarters · 4 analysts